CHARITABLE
More than 500 results
CHARITABLE
-
Allen Matkins' commitment to quality is the engine that has driven our growth and reputation over our initial 30 years of practice as a firm. Our strength lies in the ability of our lawyers to bring creative solutions to complex issues, turning problems into opportunities. With more than 240 lawyers situated in five major business centers in California, our practice is not merely statewide, but national and international in scope. We serve long-standing and new clients who expect and receive superior quality work and service. It is our belief that the relationship between our clients and our lawyers is unique and that the best interests of our clients are served by long-standing individual relationships and personalized service.
-
Just as commitment to quality is the engine of the firm's growth, commitment to community is the firm's foundation - the Allen Matkins community itself and the larger communities in which we live and work. We are profoundly aware that people are our core asset, and that, as a service business, people are whom we serve. We strive to ensure that, in addition to having outstanding academic credentials, each person who joins our team of professionals demonstrates respect for the contributions of others.
-
-
YPC's mission is to promote an environment that attracts and retains young professionals in Greater Des Moines. Our efforts focus on connecting YP's to each other and to the community through social, civic, charitable, & professional development endeavors.
-
The West Suburban YMCA, located in Newton, Massachusetts, is a nonprofit community service organization made possible because of charitable donations, member support, and dedicated volunteers and staff. The YMCA is devoted to the education, physical health, mental well-being and moral development of children, families, and communities and is committed to this simple policy: Nobody will be turned away from our programs and facilities due to an inability to pay. The Y strives to incorporate all its programs with the core values of honesty, caring, respect, and responsibility.
-
Greater Elgin Area YMCA, Elgin, Illinois
-
Attend with your family and friends and join other congregants from all over South Florida, in this God given once a week celebration of life! The greatest of all miracles, and our mitzvah, is to bring to the heart of a person, the Holy Influence, so, one may be enabled to pray with others, to their Creator. Music and a beautiful “House of Worship”, are essential in creating an inspirational atmosphere, for meditation and prayer. Join us in our Jewish traditions, for an uplifting Judaic experience, a “Shabbat Service from the Heart”. We look forward to your presence.
-
Giant Eagle®, Market District®, Giant Eagle Express®, and GetGo® — our stores offer variety and value every day. Energy conservation efforts, environmentally friendly stores, and alternative fuels at GetGo® — Giant Eagle® is doing our part to preserve the planet we call home.
-
The 911 Cell Phone Bank is an initiative of The Charitable Recycling Foundation, Inc. an IRS recognized 501(c)(3) non-profit organization (Tax ID - 20-5050475). In May of 2004, the 911 Cell Phone Bank was created to provide an ongoing and readily available source of emergency cell phones and funds to meet the unexpected and urgent needs of participating law enforcement and affiliated victims services agencies. Since then, the 911 Cell Phone Bank has generated hundreds of thousands of dollars and provided thousands of emergency cell phones for victims services organizations nationwide. We have successfully relieved the operational burden of managing a emergency cell phone program from our participants.
-
In 1984, the first AbilityFirst accessible apartment complex opened its doors, in Glendale, California. Today, our housing program has grown to include 10 apartment complexes, a “family-style” adult residential facility, and a residential home for seniors. We are happy to announce that our newest apartment complex, and our first in Orange County, is now open Recognizing the critical need for accessible, affordable housing, AbilityFirst has become a leader in building and operating residential facilities for individuals with physical and developmental disabilities. This commitment reflects our mission to help children and adults with disabilities realize their full potential throughout their lives.
-
Recognizing the critical need for accessible, affordable housing, AbilityFirst has become a leader in building and operating residential facilities for individuals with physical and developmental disabilities. This commitment reflects our mission to help children and adults with disabilities realize their full potential throughout their lives. In 1984, the first AbilityFirst accessible apartment complex opened its doors, in Glendale, California. Today, our housing program has grown to include 10 apartment complexes, a “family-style” adult residential facility, and a residential home for seniors. We are happy to announce that our newest apartment complex, and our first in Orange County, is now open.
-
-
The new Ayres Hotel Redlands pays homage to the relaxed style of Santa Barbara architecture via brilliant sunwashed white stucco surfaces and distinguished wrought iron ornamental details similar to the picturesque homes found in quaint Mediterranean towns. Inside, guests delight in the gracious hotel lobby that offers a cozy fireplace perfect for fireside chats or reading a beloved book. Throughout the hotel, hand-selected antiques add to its European flair and fine art adorns the walls, creating an atmosphere that is both warm and inspiring. Here, comfort and style go hand in hand, inviting you to relax and enjoy all that Redlands has to offer.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We provide the means, the opportunity, and the structure for community-minded individuals and corporations to make an ongoing and lasting impact on their communities. Through our direct partnership with hundreds of shelters, we place our Night Night Packages in the hands of over 25, 000 homeless children each year. Project Night Night offers a comprehensive approach to assistance by impacting as many areas in need as possible. We help the environment by establishing drop-off locations where individuals can donate their like-new children's items rather than seeing them disposed of into landfills. We also focus on the education of homeless children by donating over 25, 000 children's books each year. Finally, we attend to the emotional needs of homeless children through the carefully-tailored comfort items that we donate in each Night Night Package.
-
Project Night Night donates over 25, 000 Night Night Packages each year, free of charge, to homeless children who need our childhood essentials to feel secure, cozy, ready to learn, and significant. Each Night Night Package contains a new security blanket, an age-appropriate children's book, and a stuffed animal -- all nestled inside of a new canvas tote bag. By providing objects of reliable comfort, Project Night Night reduces trauma and advances the emotional and cognitive well-being of the children we serve. Every child who receives one of our Night Night Packages leaves the shelter owning a book which encourages reading and family bonding, a security blanket which can be cuddled, and a stuffed animal which can become a cherished friend. We have one objective – to deliver our Night Night Packages to every homeless child in the country who needs one.
-
AbilityFirst provides programs and services to help children and adults with physical and developmental disabilities reach their full potential throughout their lives. We offer a broad range of employment, recreational and socialization programs and operate 12 accessible residential housing complexes. When our organization was founded, the name reflected the thinking and norms of the time. The ensuing decades, however, brought dramatic change. We expanded to provide programs for adults, as well as children. We also broadened our mission in order to meet the needs of those with developmental disabilities, as well as those with physical disabilities. Development disabilities include autism, cerebral palsy, Down syndrome, and epilepsy.
-
Today, our housing program has grown to include 10 apartment complexes, a “family-style” adult residential facility, and a residential home for seniors. We are happy to announce that our newest apartment complex, and our first in Orange County, is now open. Recognizing the critical need for accessible, affordable housing, AbilityFirst has become a leader in building and operating residential facilities for individuals with physical and developmental disabilities. This commitment reflects our mission to help children and adults with disabilities realize their full potential throughout their lives. In 1984, the first AbilityFirst accessible apartment complex opened its doors, in Glendale, California.
-
Harry Lloyd (1926–1997) had great passion for helping others achieve their dreams. Through his inspiration, encouragement, and support many received opportunities and attained successes beyond their imagination. Prior to his death caused by melanoma cancer, Mr. Lloyd established The Harry J. Lloyd Charitable Trust. In 2003, The Harry J. Lloyd Charitable Trust established a melanoma advisory committee to assist the seven trustees in identifying and reviewing melanoma research grant requests. In eight years, the trust has provided 70 melanoma research grants totaling more than $6.5 million.
-
The Hearst Foundations are national philanthropic resources for organizations and institutions working in the fields of Education, Health, Culture and Social Service. Our goal is to ensure that people of all backgrounds have the opportunity to build healthy, productive and inspiring lives. The charitable goals of the Foundations reflect the philanthropic interests of William Randolph Hearst. The Hearst Foundation, Inc. was founded in 1945 by publisher/philanthropist William Randolph Hearst. In 1948, Mr. Hearst established the California Charities Foundation, renamed the William Randolph Hearst Foundation in 1951. Both Foundations are national private philanthropies operating independently from The Hearst Corporation.
-
One of the largest supporters of arts in the world, the J. Paul Getty Trust is an international cultural and philanthropic institution that focuses on the visual arts in all their dimensions. The Getty serves both the general public and a wide range of professional communities in Los Angeles and throughout the world. Through the work of the four Getty programs—the Museum, Research Institute, Conservation Institute, and Foundation—the Getty aims to further knowledge and nurture critical seeing through the growth and presentation of its collections and by advancing the understanding and preservation of the world's artistic heritage. The Getty pursues this mission with the conviction that cultural awareness, creativity, and aesthetic enjoyment are essential to a vital and civil society.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JUVENILE DIABETES RESEARCH FOUNDATION
IN, 46240 INDIANAPOLIS, 8440 WOODFIELD CROSSING BLVD, SUITE 201
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JUVENILE DIABETES RESEARCH FOUNDATION
GA, 30305 ATLANTA, 3525 PIEDMONT ROAD, NE BUILDING 6, SUITE 300
The Georgia Chapter is here to assist those affected by type 1 diabetes by offering one-to-one connections, providing useful resources, hosting educational programs and advancing the search for a cure with an active advocacy program. Through the success of our premier fundraising events including, Walk to Cure, Hope for a Cure Gala, Ride to Cure and Rock the Cure, the Georgia Chapter proudly raised over $4.6 million for diabetes research in 2009. The Juvenile Diabetes Research Foundation (JDRF) is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. Since our founding in 1970 by parents of children with type 1 diabetes our mission has remained constant, to find a cure.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
Massey Knakal is the New York metropolitan area's premier full service sales company, specializing in the sale of investment and user properties. With over 100 employees, four offices and thorough coverage of the five boroughs of New York City, Westchester County, Long Island and New Jersey, Massey Knakal Realty Services dominates the New York metropolitan area's building sales marketplace. Massey Knakal believes that property owners deserve the highest and most sophisticated level of advocacy and representation. We are committed to building upon our tradition of exclusively representing owners, delivering superior results, and maintaining our industry leadership position. We serve our clients with distinction, provide personal and professional growth for our people, and are a positive force in the communities we touch, while always embracing our values of passion, integrity, excellence and responsibility.
-
Massey Knakal is the New York metropolitan area's premier full service sales company, specializing in the sale of investment and user properties. With over 100 employees, four offices and thorough coverage of the five boroughs of New York City, Westchester County, Long Island and New Jersey, Massey Knakal Realty Services dominates the New York metropolitan area's building sales marketplace. Massey Knakal believes that property owners deserve the highest and most sophisticated level of advocacy and representation. We are committed to building upon our tradition of exclusively representing owners, delivering superior results, and maintaining our industry leadership position. We serve our clients with distinction, provide personal and professional growth for our people, and are a positive force in the communities we touch, while always embracing our values of passion, integrity, excellence and responsibility.
-
To be in the Charitable Choices web site, national or international charities must be part of the federal government’s on-the-job fund-raising campaign, the Combined Federal Campaign. Charitable Choices will not receive any part of your donation. We will not receive any of your personal information. Indeed, we will not know if you make a donation or not.
-
Dedicated to providing excellent healthcare services since 1918, Orlando Health offers crucial, life saving services to our community. These critical services include the only Level One (the highest level) Trauma Center in Central Florida, the only Level III (the highest level) Neonatal Unit in Central Florida, and a cancer program affiliated with the top cancer center in the nation. Orlando Health Foundation is committed to partnering with caring individuals, foundations and organizations to raise crucial funds for Orlando Health.
